Patents Examined by Michael McGraw
  • Patent number: 6899884
    Abstract: A new mumps vaccine is presented, comprising a homogeneous pure isolate derived from the Jeryl-Lynn strain of mumps virus. In a preferred embodiment of the invention the vaccine produces higher seroconversion and anitbody titres than know commercial vaccines.
    Type: Grant
    Filed: November 3, 2003
    Date of Patent: May 31, 2005
    Assignee: SmithKline Beecham Biologicals, s.a.
    Inventors: Nigel Maurice Harford, Brigitte Desiree Alberte Colau, Jean Didelez